Latest Kaiser Health News Stories
KHN’s Sarah Jane Tribble explains the key elements of the Trump blueprint on CBS News’ “Red & Blue.”
The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
Anthem, one of the country’s largest insurers, has cut the reimbursement rate it pays for breast pumps by nearly half, fueling concerns that new moms — especially ones with lower incomes — will not be able to afford the pumps they need.
Even under a decent plan, you’ll have to dig deep in your pocket for crowns, bridges and implants. The mouth isn’t covered by insurance the same way as the rest of the body, and this division has deep roots in history and tradition.
Guess who’s back grabbing headlines? Pharmacy benefit managers — those companies that serve as middlemen in the prescription drug pipeline.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
A crowdsourced investigation by KHN and NPR gives voice to those who are puzzled and outraged by medical invoices.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
In a case with possible national repercussions, the state’s attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children’s Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
Even voters who say they are more enthusiastic about voting in this congressional election than in past ones are not motivated by any specific issue. But, according to a poll out Thursday, health care policies rank high among topics voters want candidates to address.
All private health plans, Medicare, state Medicaid programs and the VA now cover some e-visits — albeit with restrictions.
President Donald Trump is recommending that Congress approve his plan to take back about $7 billion in funding for the Children’s Health Insurance Plan. Experts are divided about whether it would have any effect.
Federal law prohibits them from using the coupons drugmakers offer to help patients cover their share of a medicine’s cost.